ask dr. domchek: management of brca-related ovarian cancer risk
Published 5 years ago • 116 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
1:31
ask dr. domchek: recent treatment options for brca-related cancers
-
1:42
ask dr. domchek: the differences between brca1 and brca2
-
5:46
ask dr. domchek: ovarian cancer surveillance & more
-
54:43
dr. susan domchek, md - executive director, basser center for brca, abramson cancer center, penn
-
2:15
ask dr. domchek: brca and individualized risk
-
1:20:23
knowledge is power: understanding and managing brca-related cancer risk
-
0:48
ask dr. domchek: breast cancer prevention in young women with brca mutations
-
40:16
changing paradigms for the treatment of ovarian cancer
-
5:49
the role of brca1 in dna damage response
-
1:50
challenges with patient selection for extended adjuvant endocrine therapy in breast cancer
-
0:37
dr. domchek discusses unanswered questions from the mediola trial
-
49:16
the abcs of cancer risk: understanding what risk means for brca mutation carriers
-
1:38
ask dr. domchek: men and brca mutations
-
1:44
about brca with dr. susan domchek
-
1:48
ask dr. domchek: determining individualized risk for hereditary cancer
-
1:14
ask dr. domchek: different types of breast cancers
-
57:02
brca mutations and ovarian cancer: what you need to know
-
1:46
ask dr. domchek: follow up guidelines for brca-related breast cancer recurrence
-
1:06
ask dr. domchek: upcoming advances in genetics
-
1:45
ask dr. domchek: enhancing parp inhibitors
-
39:29
knowledge is power: understanding and managing brca-related cancer risk in berkeley, ca
-
1:22
brca and ovarian cancer